SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: margie who wrote (5785)12/19/1998 11:49:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 6136
 
Quite a few reports on Ziagen approval which are linked to the anti-HIV table under New Therapeutics at biocognizance.com
Table is also linked to a more complete portion on last month's Paine Webber review on anti-HIV agents.



To: margie who wrote (5785)12/20/1998 2:24:00 PM
From: billkirn  Respond to of 6136
 
Margie: Sustiva and Viracept combo effective for 80% of the people who have previously failed drug therapy. Wow! That is significant!
Bill